Veeda Group Transforms into Veeda Lifesciences
Veeda Group has successfully rebranded itself as Veeda Lifesciences, marking a significant leap in its mission to enhance drug development services. This rebranding is not just about a new logo but signifies a pivotal transition from a generics-focused Contract Research Organization (CRO) to a more comprehensive drug development services provider. This evolution indicates Veeda's commitment to serving various modalities of drugs, including both generics and innovative chemical and biological entities.
New Brand, Broader Scope
The launch of Veeda Lifesciences introduces four strategic business units: Clinical Trials, Healthy Volunteer Services, Biopharma Services, and Preclinical & Non-Clinical Testing Services. This structure allows Veeda to operate as an integrated research service provider, offering an extensive range of services to meet growing demands in the life sciences and healthcare sectors.
Comprehensive Services Across Drug Development
Veeda Lifesciences integrates various subsidiary companies such as Veeda Clinical Research and Health Data Specialists, demonstrating a commitment to offering research services that span across the complete drug development value chain. From initial discovery and preclinical research to later-phase development, Veeda Lifesciences is embracing a holistic approach to drug development.
Driving Innovation with Technology
Emphasizing its transition to a CRO-CDMO model, Veeda Lifesciences is leveraging artificial intelligence and real-world data to enhance its service offerings. By incorporating cutting-edge technology into its operations, the company aims to refine processes and provide improved outcomes for its clients and the patients they serve.
Leadership Insights on Future Directions
Dr. Mahesh Bhalgat, the Group CEO and Managing Director, expressed that the new name and logo are designed to reflect the organization’s progressive outlook and commitment to core values of innovation and client satisfaction. He noted that this new identity elevates their aspirations while striving to meet the evolving needs of the industry.
Company Growth and Global Reach
Founded in 2004, Veeda Lifesciences has expanded its footprint across five countries, successfully conducting clinical trials in 26 geographical regions. The strategic acquisition of Bioneeds has facilitated Veeda's entrance into preclinical services, allowing it to diversify its service portfolio significantly.
Expertise Across Multiple Domains
The Clinical Trials unit within Veeda focuses on a wide array of operations, including those previously held by Health Data Specialists, ensuring a comprehensive approach to patient-centered trials. The Healthy Volunteer Services unit is headquartered in Gujarat and is known for its clinical bioanalysis expertise concerning small molecules. Furthermore, the Biopharma Services division operates out of Bengaluru, specializing in the analytical characterization and development of biologics, ensuring that the company remains at the forefront of modern drug development.
Commitment to Quality and Innovation
Veeda Lifesciences centers its operations around delivering quality and scientific excellence. The company continuously invests in talent and technology to support its clients in developing innovative therapies. This commitment positions Veeda as a crucial partner for biotech and pharmaceutical companies navigating the complex landscape of drug development.
About Veeda Lifesciences
Veeda Lifesciences is committed to providing full and functional services throughout the drug development lifecycle. With capabilities that span from preclinical trials to clinical pharmacology, the company is poised to assist biotech and pharmaceutical firms across various therapeutic domains. By utilizing advanced real-world data and AI platforms, Veeda accelerates the drug development pipeline, ensuring that clients can meet their objectives efficiently and effectively. Veeda Lifesciences is dedicated to supporting the global healthcare community by developing groundbreaking therapies and generic medications.
Frequently Asked Questions
1. What does the rebranding mean for Veeda Lifesciences?
The rebranding reflects Veeda's evolution from a generics-focused CRO to a comprehensive drug development services provider, enhancing its service offerings across multiple drug modalities.
2. How many business units does Veeda Lifesciences have?
Veeda Lifesciences operates through four strategic business units: Clinical Trials, Healthy Volunteer Services, Biopharma Services, and Preclinical & Non-Clinical Testing Services.
3. What technologies is Veeda Lifesciences utilizing?
Veeda Lifesciences is leveraging artificial intelligence and real-world data to optimize its service offerings and improve outcomes for its clients.
4. How has Veeda expanded its global presence?
Since its founding in 2004, Veeda Lifesciences has expanded to five countries and conducts trials in 26 regions worldwide.
5. What industries does Veeda Lifesciences support?
Veeda Lifesciences provides services primarily to the life sciences and healthcare industries, working with reputable sponsors and global pharma companies.
